Browsing: Therapeutics
Driving the sector wave. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) surged 7.0% to $104.39 on Tuesday, April 14, 2026, as a…
Loss Per Share (GAAP) $0.26 Loss narrows sharply. Dogwood Therapeutics, Inc. (NASDAQ: DWTX) reported a lack of $0.26 per share…
Observe Mineralys Therapeutics, Inc. (MLYS) This autumn 2025 Earnings Name March 12, 2026 4:30 PM EDT Firm Contributors Jon Congleton…
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is without doubt one of the 12 Shares that Will Bounce Again Based on Wall Road…
Featured Podcasts Decoder with Nilay Patel: The corporate on the coronary heart of the AI bubble A present from the…
Flex Level Safety Aquestive Therapeutics (NASDAQ:AQST) is rapidly approaching a key topline knowledge readout for the Anaphylm (epinephrine) sublingual movie…
Dr_Microbe/iStock through Getty Photos Corcept Therapeutics (NASDAQ:CORT) plummeted 38% in after-hours buying and selling on Friday after a loss in…
Pharma main Solar Pharmaceutical on Monday knowledgeable that it has entered into an settlement to accumulate 16.7 per cent stake…
Drew Angerer/Getty Photos Information Bristol-Myers Squibb (NYSE:BMY) agreed to buy Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY) agreed…
JHVEPhoto/iStock Editorial by way of Getty Photos Amgen (NASDAQ:AMGN) mentioned that the Federal Commerce Fee’s lawsuit to problem its deliberate…